Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for Agitation in Alzheimer's Disease
NCT00898807Phase 3Completed
- Sponsor
- Johns Hopkins Center for Clinical Trials and Evidence Synthesis
- Start
- Jul 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of citalopram in Alzheimer's disease (AD), sponsored by Johns Hopkins Center for Clinical Trials and Evidence Synthesis. Started Jul 2009; status: completed.
02
Drugs
citalopram
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00898807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00898807.